IN VITRO AND IN VIVO EFFECT OF AN ORAL IRON CHELATOR DEFERASIROX IN MYELOID LEUKEMIA CELLS

被引：0
|
作者：
Choi, C. W. [1 ]
Kim, J. L. [2 ]
Kang, H. N. [2 ]
Kang, M. H. [2 ]
Yoo, Y. A. [2 ]
机构：
[1] Korea Univ, Guru Teg Bahadur Hosp, Seoul, South Korea
[2] Korea Univ, Coll Med, Grad Sch Med, Seoul 136705, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0639
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [21] Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells
    Legendre, Claire
    Avril, Sylvie
    Guillet, Catherine
    Garcion, Emmanuel
    BMC CANCER, 2016, 16
  • [22] Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload
    Chen, Cheng-Hsu
    Shu, Kuo-Hsiung
    Yang, Youngsen
    HEMATOLOGY, 2015, 20 (05) : 304 - 310
  • [23] Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells
    Claire Legendre
    Sylvie Avril
    Catherine Guillet
    Emmanuel Garcion
    BMC Cancer, 16
  • [24] The new oral iron chelator, Deferasirox, is the new drug to prevent Liver Fibrosis and Hepatocarcinogenesis
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Uchida, Koichi
    Tanabe, Norikazu
    Takami, Taro
    Saeki, Issei
    Fujisawa, Koichi
    Maeda, Masaki
    Terai, Shuji
    Sakaida, Isao
    HEPATOLOGY, 2013, 58 : 1084A - 1085A
  • [25] The oral iron chelator, deferasirox, may be a novel potential therapeutic agent for pancreatic cancer
    Harima, Hirofumi
    Kaino, Seiji
    Shinoda, Shuhei
    Kawano, Michitaka
    Suenaga, Shigeyuki
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Sakaida, Isao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 34 - 34
  • [26] THE IRON CHELATOR DEFERASIROX AFFECTS REDOX SIGNALING IN HEALTHY HEMATOPOIETIC STEM CELLS
    Tataranni, T.
    Agriesti, F.
    Mazzoccoli, C.
    Ruggieri, V.
    Laurenzana, I.
    D'Auria, F.
    Falzetti, F.
    Di Ianni, M.
    Capitanio, N.
    Musto, P.
    Piccoli, C.
    HAEMATOLOGICA, 2014, 99 : 177 - 178
  • [27] Growth Inhibition of Human Breast Cancer Cells with an Iron Chelator (Deferasirox) and Docetaxel
    Lipton, A.
    Witters, L.
    Nick, H.
    CANCER RESEARCH, 2009, 69 (24) : 790S - 790S
  • [28] Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator
    Salehi, Samie
    Saljooghi, Amir Sh.
    Shiri, Ali
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 781 : 209 - 217
  • [29] Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis
    Puri, Sumant
    Kumar, Rohitashw
    Rojas, Isolde G.
    Salvatori, Ornella
    Edgerton, Mira
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [30] The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells
    Tataranni, Tiziana
    Agriesti, Francesca
    Mazzoccoli, Carmela
    Ruggieri, Vitalba
    Scrima, Rosella
    Laurenzana, Ilaria
    D'Auria, Fiorella
    Falzetti, Franca
    Di Ianni, Mauro
    Musto, Pellegrino
    Capitanio, Nazzareno
    Piccoli, Claudia
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (02) : 236 - 246
12345